REQUEST A DEMO
Total
USD $0.00
Search more companies

Jacobio Pharmaceuticals Group Company Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jacobio Pharmaceuticals Group Company Limited Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Jacobio Pharmaceuticals Group Company Limited is a high-tech enterprise under the Huahai Group, responsible for investment, development, and management of microelectronics business. It is a comprehensive microelectronics company with significant influence in China. Since 2004, it has been consistently recognized as one of the top 100 electronic information companies by the Ministry of Industry and Information Technology. The company focuses on revitalizing the national microelectronics industry and specializes in areas such as analog and power semiconductors. Its goal is to become a leading semiconductor company in China with a inclusive culture, innovative spirit, excellent performance, and industry leadership, providing high-quality products and system solutions for building a harmonious and efficient society. The company's business includes integrated circuit design, mask manufacturing, wafer manufacturing, packaging testing, and discrete devices. It operates in various locations including Wuxi, Shenzhen, Shanghai, Chongqing, Hong Kong, and Taiwan. Currently, it has five 6-8 inch wafer production lines, two packaging production lines, one mask production line, and three design companies. It is a domestic enterprise with a complete semiconductor industry chain and a leading position in characteristic manufacturing process technology. Along with its growth, the company also emphasizes social responsibility and continuously carries out environmental protection and energy conservation work. It has been awarded the "Advanced Collective for Energy Conservation in the Eleventh Five-Year Plan" by the Jiangsu Provincial People's Government and the title of "Type II Social Enterprise for Resource Conservation and Environmental Friendliness" by the Wuxi Municipal Government. It has also been rated as the highest level "Green" enterprise in the "Environmental Behavior Rating of the Yangtze River Delta Region" for four consecutive years.

Headquarters
Building F2, No. 88, Kechuang 6Th Street, Beijing Economic-Technological, Development Area
Beijing; Beijing;

Contact Details: Purchase the Jacobio Pharmaceuticals Group Company Limited report to view the information.

Website: http://www.jacobiopharma.com

Basic Information
Total Employees:
Purchase the Jacobio Pharmaceuticals Group Company Limited report to view the information.
Outstanding Shares:
Purchase the Jacobio Pharmaceuticals Group Company Limited report to view the information.
Registered Capital:
Purchase the Jacobio Pharmaceuticals Group Company Limited report to view the information.
Financial Auditors:
Purchase the Jacobio Pharmaceuticals Group Company Limited report to view the information.
Incorporation Date:
June 01, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Beijing Jacobio
Jacomab Pharmaceuticals Co Ltd
Company Performance
Financial values in the chart are available after Jacobio Pharmaceuticals Group Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-26.24%
Total operating revenue
-24.74%
Operating profit (EBIT)
-71.34%
EBITDA
-72.55%
Net Profit (Loss) for the Period
-30.08%
Total assets
-0.39%
Total equity
-16.71%
Operating Profit Margin (ROS)
-308.96%
Net Profit Margin
-178.51%
Return on Equity (ROE)
-4.74%
Debt to Equity Ratio
15.79%
Quick Ratio
-11.81%
Cash Ratio
-11.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?